Nano Delivery System for Atherosclerosis

Atherosclerosis, a pathological process propelled by inflammatory mediators and lipids, is a principal contributor to cardiovascular disease incidents. Currently, drug therapy, the primary therapeutic strategy for atherosclerosis, faces challenges such as poor stability and significant side effects. The advent of nanomaterials has garnered considerable attention from scientific researchers. Nanoparticles, such as liposomes and polymeric nanoparticles, have been developed for drug delivery in atherosclerosis treatment. This review will focus on how nanoparticles effectively improve drug safety and efficacy, as well as the continuous development and optimization of nanoparticles of the same material and further explore current challenges and future opportunities in this field.

• Publication year

  2024

• Venue

  Journal of Functional Biomaterials

• Publication date

  2024-12-24

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.3390/jfb16010002PMID 39852558PMCID 11766408
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neutrophil extracellular traps: a catalyst for atherosclerosis

  2024cited by this paper
• Transition-metal-based nanozymes for biosensing and catalytic tumor therapy

  2024cited by this paper
• Recent developments of polymeric delivery systems in gene therapeutics

  2024cited by this paper
• A Macrophage Membrane‐Functionalized, Reactive Oxygen Species‐Activatable Nanoprodrug to Alleviate Inflammation and Improve the Lipid Metabolism for Atherosclerosis Management

  2024cited by this paper
• Impact of rise and fall phases of shear on platelet activation and aggregation using microfluidics

  2024cited by this paper
• Next-generation pediatric care: nanotechnology-based and AI-driven solutions for cardiovascular, respiratory, and gastrointestinal disorders

  2024cited by this paper
• Lipid nanoparticles encapsulating curcumin for imaging and stabilization of vulnerable atherosclerotic plaques via phagocytic "eat-me" signals.

  2024cited by this paper
• A Zombie Macrophage‐Based “Trojan horse” Enhances the Effect of Efferocytosis Through Immune Regulation for Atherosclerosis Treatment

  2024cited by this paper
• Tailoring Zinc Ferrite Nanoparticle Surface Coating for Macrophage-Affinity Magnetic Resonance Imaging of Atherosclerosis.

  2024cited by this paper
• Piezocatalytic Schottky Junction Treats Atherosclerosis by a Biomimetic Trojan Horse Strategy

  2024cited by this paper
• Macrophage Membrane-Encapsulated Dopamine-Modified Poly Cyclodextrin Multifunctional Biomimetic Nanoparticles for Atherosclerosis Therapy.

  2024cited by this paper
• Dual-modality probe nanodrug delivery systems with ROS-sensitivity for atherosclerosis diagnosis and therapy.

  2024cited by this paper
• Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy.

  2024cited by this paper
• A Dual‐Function CD47‐Targeting Nano‐Drug Delivery System Used to Regulate Immune and Anti‐Inflammatory Activities in the Treatment of Atherosclerosis

  2024cited by this paper
• Engineered M2 macrophage-derived extracellular vesicles with platelet membrane fusion for targeted therapy of atherosclerosis

  2024cited by this paper
• Targeting Ferroptosis: A Novel Strategy for the Treatment of Atherosclerosis.

  2024cited by this paper
• Curcumin Equipped Nanozyme‐Like Metal−Organic Framework Platform for the Targeted Atherosclerosis Treatment with Lipid Regulation and Enhanced Magnetic Resonance Imaging Capability

  2024cited by this paper
• Targeted delivery of rapamycin and inhibition of platelet adhesion with multifunctional peptide nanoparticles for atherosclerosis treatment.

  2024cited by this paper
• Enhancing CAR Macrophage Efferocytosis Via Surface Engineered Lipid Nanoparticles Targeting LXR Signaling

  2024cited by this paper
• Polydopamine-based nanostructures: A new generation of versatile, multi-tasking, and smart theranostic tools

  2024cited by this paper
• Codelivery of Dual Gases with Metal-Organic Supramolecular Cage-Based Microenvironment-Responsive Nanomedicine for Atherosclerosis Therapy.

  2024cited by this paper
• Biomimetic Platelet‐Cloaked Nanoparticles for the Delivery of Anti‐Inflammatory Curcumin in the Treatment of Atherosclerosis

  2024cited by this paper
• Cluster of Differentiation-44-Targeting Prussian Blue Nanoparticles Onloaded with Colchicine for Atherosclerotic Plaque Regression in a Mice Model.

  2024cited by this paper
• Endothelium-targeted NF-κB siRNA nanogel for magnetic resonance imaging and visualized-anti-inflammation treatment of atherosclerosis.

  2024cited by this paper
• GPx-like phenolic-amine nanoparticles with onion peel-off model for constantly generative anti-inflammation and anti-oxidation capability

  2024cited by this paper
• CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques.

  2023cited by this paper
• Neutrophil-Membrane-Coated Biomineralized Metal-Organic Framework Nanoparticles for Atherosclerosis Treatment by Targeting Gene Silencing.

  2023cited by this paper
• Scavenger receptor-AI targeted theranostic nanoparticles for regression of atherosclerotic plaques via ABCA1 modulation.

  2023cited by this paper
• Ultrasound-assisted biomimetic nanobubbles for targeted treatment of atherosclerosis.

  2023cited by this paper
• Reduction of Reactive Oxygen Species Accumulation Using Gadolinium-Doped Ceria for the Alleviation of Atherosclerosis.

  2023cited by this paper
• Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles.

  2023cited by this paper
• Monitoring the Progression of Early Atherosclerosis Using a Fluorescence Nanoprobe for the Detection and Imaging of Phosphorylation and Glucose Levels.

  2023cited by this paper
• Poly(β-amino ester)s-based nanovehicles: Structural regulation and gene delivery

  2023cited by this paper
• Anti-CXCR2 antibody-coated nanoparticles with an erythrocyte-platelet hybrid membrane layer for atherosclerosis therapy.

  2023cited by this paper
• The emerging role of Th1 cells in atherosclerosis and its implications for therapy

  2023cited by this paper
• Polydopamine nanoparticle-mediated mild photothermal therapy for inhibiting atherosclerotic plaque progression by regulating lipid metabolism of foam cells

  2023cited by this paper
• MiR-146a encapsulated liposomes reduce vascular inflammatory responses through decrease of ICAM-1 expression, macrophage activation, and foam cell formation.

  2023cited by this paper
• A bio-inspired nanoparticle coating for vascular healing and immunomodulatory by cGMP-PKG and NF-kappa B signaling pathways.

  2023cited by this paper
• An anti-inflammatory Glyburide-loaded nanoghost for atherosclerosis therapy: a red blood cell based bio-mimetic strategy

  2023cited by this paper
• Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF-κB/NLRP3 pathways in inflammatory endothelial cells

  2023cited by this paper
• Near Infrared Light‐Activatable Platelet‐Mimicking NIR‐II NO Nano‐Prodrug for Precise Atherosclerosis Theranostics

  2023cited by this paper
• Biomimetic Targeting Nanoplatform for Atherosclerosis Theranostics Via Photoacoustic Diagnosis and “Hand‐In‐Hand” Immunoregulation

  2023cited by this paper
• Advances in magnetic nanoparticle-based magnetic resonance imaging contrast agents

  2023cited by this paper
• Cyclodextrin-loaded nanobubbles reduce cholesterol and atherosclerosis in vivo

  2023cited by this paper
• An Elastase-inhibiting, Plaque-targeting and Neutrophil-hitchhiking Liposome Against Atherosclerosis.

  2023cited by this paper
• Exploring atherosclerosis imaging with contrast-enhanced MRI using PEGylated ultrasmall iron oxide nanoparticles

  2023cited by this paper
• M2 Macrophage Membrane-Camouflaged Fe3 O4 -Cy7 Nanoparticles with Reduced Immunogenicity for Targeted NIR/MR Imaging of Atherosclerosis.

  2023cited by this paper
• Biomimetic nanoparticles to enhance the reverse cholesterol transport for selectively inhibiting development into foam cell in atherosclerosis

  2023cited by this paper
• Recent Development and Advancement in Quantum Dots in Pharmaceutical and Biomedical Fields for the Delivery of Drugs

  2023cited by this paper
• Anti-inflammation-based treatment of atherosclerosis using Gliclazide-loaded biomimetic nanoghosts

  2023cited by this paper
• A study of lovastatin and L-arginine co-loaded PLGA nanomedicine for enhancing nitric oxide production and eNOS expression.

  2022cited by this paper
• Hyaluronic acid-guided assembly of ceria nanozymes as plaque-targeting ROS scavengers for anti-atherosclerotic therapy.

  2022cited by this paper
• Dual-Emission ZAISe/ZnS quantum dots for Multi-level Bio-Imaging: Foam cells and atherosclerotic plaque imaging.

  2022cited by this paper
• Red blood cell biomimetic nanoparticle with anti-inflammatory, anti-oxidative and hypolipidemia effect ameliorated atherosclerosis therapy.

  2022cited by this paper
• Plaque‐Targeted Rapamycin Spherical Nucleic Acids for Synergistic Atherosclerosis Treatment

  2022cited by this paper
• Pro-efferocytic macrophage membrane biomimetic nanoparticles for the synergistic treatment of atherosclerosis via competition effect

  2022cited by this paper
• Biomimetic nanomedicines for precise atherosclerosis theranostics

  2022cited by this paper
• Platelets, a Key Cell in Inflammation and Atherosclerosis Progression

  2022cited by this paper
• Targeted Imaging in Atherosclerosis.

  2022cited by this paper
• Hyaluronic acid targeted and pH-responsive multifunctional nanoparticles for chemo-photothermal synergistic therapy of atherosclerosis.

  2022cited by this paper
• Macrophage membrane-coated nanovesicles for dual-targeted drug delivery to inhibit tumor and induce macrophage polarization

  2022cited by this paper
• Intravital lipid droplet labeling and imaging reveals the phenotypes and functions of individual macrophages in vivo

  2022cited by this paper
• Artificial Intelligence in Cardiovascular Atherosclerosis Imaging

  2022cited by this paper
• Reactive oxygen species (ROS)-responsive size-reducible nanoassemblies for deeper atherosclerotic plaque penetration and enhanced macrophage-targeted drug delivery

  2022cited by this paper
• Targeted delivery of platelet membrane modified extracellular vesicles into atherosclerotic plaque to regress atherosclerosis

  2022cited by this paper
• Progress in oral insulin delivery by PLGA nanoparticles for the management of diabetes.

  2022cited by this paper
• Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis.

  2022cited by this paper
• Poly (beta‐amino ester) as an in vivo nanocarrier for therapeutic nucleic acids

  2022cited by this paper
• Controlled release and targeted drug delivery with poly(lactic-co-glycolic acid) nanoparticles: reviewing two decades of research

  2022cited by this paper
• Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis.

  2022cited by this paper
• Inflammatory endothelium-targeted and cathepsin responsive nanoparticles are effective against atherosclerosis

  2022cited by this paper
• Atherosclerotic plaque-targeted nanotherapeutics ameliorates atherogenesis by blocking macrophage-driven inflammation

  2022cited by this paper
• Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin.

  2022cited by this paper
• Hyaluronic Acid-Functionalized Mesoporous Silica Nanoparticles Loading Simvastatin for Targeted Therapy of Atherosclerosis

  2022cited by this paper
• Dextran-Mimetic Quantum Dots for Multimodal Macrophage Imaging In Vivo, Ex Vivo, and In Situ.

  2022cited by this paper
• Proteomic Characterization of Atherosclerotic Lesions In Situ Using Percutaneous Coronary Intervention Angioplasty Balloons—Brief Report

  2022cited by this paper
• Ratiometric fluorescence biosensor for imaging of protein phosphorylation levels in atherosclerosis mice.

  2022cited by this paper
• Targeting and promoting atherosclerosis regression using hybrid membrane coated nanomaterials via alleviated inflammation and enhanced autophagy

  2022cited by this paper
• Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages

  2022cited by this paper
• Multifunctional mesoporous silica-based nanocomposites: Synthesis and biomedical applications

  2022cited by this paper
• How Advancing are Mesoporous Silica Nanoparticles? A Comprehensive Review of the Literature

  2022cited by this paper
• Biomimetic Macrophage Membrane and Lipidated Peptide Hybrid Nanovesicles for Atherosclerosis Therapy

  2022cited by this paper
• Design and Development of Branched Poly(ß-aminoester) Nanoparticles for Interleukin-10 Gene Delivery in a Mouse Model of Atherosclerosis.

  2022cited by this paper
• Platelet Membrane Biomimetic Nanoparticles Combined With UTMD to Improve the Stability of Atherosclerotic Plaques

  2022cited by this paper
• Platelet Membrane-Coated Nanocarriers Targeting Plaques to Deliver Anti-CD47 Antibody for Atherosclerotic Therapy

  2022cited by this paper
• Immunomodulatory roles of selenium nanoparticles: Novel arts for potential immunotherapy strategy development

  2022cited by this paper
• Dual-responsive Targeted Atherosclerosis Therapy through a Multi-effective Nanoplatform with Anti-inflammatory, Lipid-regulating and Autophagy

  2022cited by this paper
• Ibrutinib Inhibits BMX-Dependent Endothelial VCAM-1 Expression In Vitro and Pro-Atherosclerotic Endothelial Activation and Platelet Adhesion In Vivo

  2022cited by this paper
• Regulation of the macrophage-related inflammatory micro-environment for atherosclerosis treatment and angiogenesis via anti-cytokine agents

  2022cited by this paper
• Recent Trends in Artificial Intelligence-Assisted Coronary Atherosclerotic Plaque Characterization

  2021cited by this paper
• CD47‐ and Integrin α4/β1‐Comodified‐Macrophage‐Membrane‐Coated Nanoparticles Enable Delivery of Colchicine to Atherosclerotic Plaque

  2021cited by this paper
• Co-Delivery of Curcumin and Bioperine via PLGA Nanoparticles to Prevent Atherosclerotic Foam Cell Formation

  2021cited by this paper
• New advances in gated materials of mesoporous silica for drug controlled release

  2021cited by this paper
• Current hurdles to the translation of nanomedicines from bench to the clinic

  2021cited by this paper
• Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics.

  2021cited by this paper
• "Plug and Play" Functionalized Erythrocyte Nanoplatform for Target Atherosclerosis Management.

  2021cited by this paper
• Enhanced Anti-Atherosclerotic Efficacy of pH-Responsively Releasable Ganglioside GM3 Delivered by Reconstituted High-Density Lipoprotein

  2021cited by this paper
• Macrophage membrane-mediated targeted drug delivery for treatment of spinal cord injury regardless of the macrophage polarization states

  2021cited by this paper
• SR-A-Targeted Nanoplatform for Sequential Photothermal/Photodynamic Ablation of Activated Macrophages to Alleviate Atherosclerosis.

  2021cited by this paper
• Shear stress and ROS-responsive biomimetic micelles for atherosclerosis via ROS consumption.

  2021cited by this paper

• Rice bran protein-based self-propelled nanomotors for targeted delivery of dihydroquercetin: A food-grade nano-system for anti-atherosclerosis.

  2026cites this paper
• BMP4 dose dictates lineage specification bias in human periodontal ligament stem cells

  2026cites this paper
• Advances in the treatment of atherosclerotic plaque based on nanomaterials.

  2025cites this paper
• Synthesis and study of amorphous calcium phosphate dual-targeted drug-carrying platforms.

  2025cites this paper
• Nanotechnology for the treatment of atherosclerosis: Strategies, Practical Applications and Future Perspectives

  2025cites this paper